• Support MPN
Logo Logo
  • Investigations
  • Analysis
  • Cartoons
  • Podcasts
  • Videos
  • Language
    • 中文
    • русский
    • Español
    • Français
    • اَلْعَرَبِيَّةُ
  • Support MPN
  • Watch | Gaza Fights Back
Cuba Covid vaccine Feature photo
Revolutionary medicine

Sovereign 2: Could Cuba’s Covid Vaccine Break Big Pharma’s Grip on Production?

US Government Fears China will Give Away COVID-19 Vaccine for Free

“The coronavirus pandemic is a clear instance in which the whole world shares a common interest in developing and distributing a vaccine.” — Dr. Dean Baker

May 4th, 2020
Alan Macleod
May 4th, 2020
By Alan Macleod
Coronavirus VACCINE Feature photo

The number of official global coronavirus mortalities surpassed a quarter of a million people today, including over 69,000 in the U.S. (although this is very likely an undercount). Polls show that the American people are extremely worried about contracting the virus. However, the government has a much bigger concern: that if they find a COVID-19

Read Full Article

The U.S. – China Tariff Dispute Is Really About Protecting US Global Corporate Dominance

Although the media largely echoes President Trump’s claim that his tariff threats directed at China about trying to reduce the large U.S. trade deficit, the president has a far narrower aim—that is to protect the monopoly position and profits of dominant U.S. corporations.

April 18th, 2018
Martin Hart-Landsberg
April 18th, 2018
By Martin Hart-Landsberg
In this April 12, 2018, photo, a man walks by a billboard displaying a Chinese company developed packaging machinery for local and foreign food and beverage companies at the International soybean exhibition in Shanghai. (AP/Andy Wong)

There is a lot of concern over the possibility of a trade war between China and the U.S. In early April, President Trump announced that his administration was considering levying $100 billion of additional tariffs on Chinese exports, after the Chinese government responded to a previously proposed U.S. tariff hike on Chinese goods of $50 billion by

Read Full Article

Despite Setbacks, The Fight To Stop TPP Spills Into 2016

An organizer opposed to the Trans-Pacific Partnership trade deal explained that everything rides on when Obama introduces the deal in Congress, adding: ‘Our job is to make sure he never has the votes.”

January 19th, 2016
Kit O'Connell
January 19th, 2016
By Kit O'Connell
TPP Trans Pacific Partnership MAP

AUSTIN, Texas --- A new year brings new challenges and new opportunities for the international movement opposed to the Trans-Pacific Partnership, a controversial trade deal that activists say threatens to allow corporate power to overrule democracy. Despite widespread opposition and controversy, President Barack Obama and other world leaders are

Read Full Article

India Blocks Colgate Patents For Commonly Used Spices

India opposed the claim using the traditional knowledge digital library (TKDL) database, created in the last decade to fight biopiracy.

July 20th, 2015
Deccan Herald
July 20th, 2015
By Deccan Herald

India has successfully blocked two patent claims of US consumer goods major Colgate-Palmolive, which wanted intellectual property right (IPR) cover on two oral compositions made from Indian spices and other herbs. One patent battle took almost seven years, after the New York-based company filed a claim at the European Patent Register on

Read Full Article

Report Clears MIT In Aaron Swartz Case; Critics Call It A ‘Whitewash’

MIT says an internal review shows the school acted appropriately in the case of Swartz.

August 1st, 2013
Katie Rucke
August 1st, 2013
By Katie Rucke
Aaron Swartz

An internal investigation by the Massachusetts Institute of Technology is billed by the school as evidence the school acted appropriately in the case of Aaron Swartz, but supporters of the late freedom-of-information advocate are calling it a “whitewash.” Swartz, 26, committed suicide after federal prosecutors targeted him for downloading academic

Read Full Article

  • Contact Us
  • Archives
  • About Us
  • Privacy Policy
© 2025 MintPress News